US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

43.36

+1.022.41%

Post-market: 43.28-0.0858-0.20%19:30 EDT

Volume:513

Turnover:22.27K

Market Cap:32.52M

PE:- -

High:43.40

Open:43.40

Low:43.28

Close:42.34

52wk High:43.40

52wk Low:29.50

Shares:750.00K

Float Shares:750.00K

Volume Ratio:0.75

T/O Rate:0.07%

Dividend:0.14

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Krystal Biotech - Discontinues Clinical Study to Advance KB801 into Pivotal Trial; no Safety Concerns Observed - SEC Filing

THOMSON REUTERS

Krystal Biotech - no Further Subject-level Updates from Discontinued Study; Pivotal Trial Results Expected in Due Course - SEC Filing

THOMSON REUTERS

Krystal Biotech - Files Response with Uspto on KB801 Patent Application - SEC Filing

THOMSON REUTERS

Construction Firm Tutor Perini Jumps on S&P Smallcap Inclusion

Ligand Pharmaceuticals Inc : Citigroup Resumes Coverage with Buy Rating; Price Target $387

THOMSON REUTERS

Ligand resumed with a Buy at Citi

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Disposes of 5,000 Shares for $115,000

Tutor Perini Set to Join the S&P SmallCap 600 Index

MT Newswires Live

Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24

Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24

S&P Dow Jones Indices Says Krystal Biotech Inc. Will Replace Taylor Morrison Home Corp. in the S&P Midcap 400

THOMSON REUTERS

Ligand price target raised to $345 from $330 at Craig-Hallum

Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91

Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 105,762 Common Shares Worth $2.39 Million

Natera Says Finalized Moldx Coverage Expands Prospera Surveillance Testing for Kidney, Heart, Lung Transplants

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64

Guardant Health is Maintained at Buy by Guggenheim

Ligand Pharmaceuticals Inc : Benchmark Raises Target Price to $335 from $275

THOMSON REUTERS

Guardant Health price target raised to $190 from $160 at Guggenheim

Natera Co-founder, Director Sheena Jonathan Sells 3,150 Shares Worth $835,835.18

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/HELX/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":43.3608,"timestamp":1787688000000,"preClose":42.3399,"halted":0,"volume":513,"hourTrading":{"tag":"盘后","latestPrice":43.275,"preClose":43.3608,"latestTime":"19:30 EDT","volume":7,"amount":303.5256,"timestamp":1787700600805,"change":-0.0858,"changeRate":-0.001979,"amplitude":0},"delay":0,"changeRate":0.02411200782240859,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Closed","change":1.0209,"latestTime":"08-25 16:00:00 EDT","open":43.4001,"high":43.4001,"low":43.275,"amount":22270.999302,"amplitude":0.002955,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":5,"adr":0,"exchange":"CBOE","adjPreClose":42.3399,"sharesOutstanding":650000,"nav":43.201,"aum":32400497.63,"dividendRate":0.003321,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":43.275,"preClose":43.3608,"latestTime":"19:30 EDT","volume":7,"amount":303.5256,"timestamp":1787700600805,"change":-0.0858,"changeRate":-0.001979,"amplitude":0},"volumeRatio":0.751318,"impliedVol":0.0938,"impliedVolPercentile":0.3665},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.751318,"shares":750000,"dividePrice":0.144,"high":43.4001,"amplitude":0.002955,"preClose":42.3399,"low":43.275,"week52Low":29.5,"pbRate":"--","week52High":43.4001,"institutionHeld":0,"latestPrice":43.3608,"eps":0,"divideRate":0.003321,"volume":513,"delay":0,"ttmEps":0,"open":43.4001,"prevYearClose":36.3062,"prevWeekClose":43.11,"prevMonthClose":38.8312,"prevQuarterClose":39.9651,"fiveDayClose":40.9918,"twentyDayClose":39.1286,"sixtyDayClose":34.2035},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653857567","title":"Krystal Biotech - Discontinues Clinical Study to Advance KB801 into Pivotal Trial; no Safety Concerns Observed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653857567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653857567?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:25","pubTimestamp":1784669159,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N18X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","KRYS","BK4139","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653785755","title":"Krystal Biotech - no Further Subject-level Updates from Discontinued Study; Pivotal Trial Results Expected in Due Course - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653785755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653785755?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:25","pubTimestamp":1784669159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N18X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRYS","BK4139","HELX","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653734785","title":"Krystal Biotech - Files Response with Uspto on KB801 Patent Application - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653734785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653734785?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:25","pubTimestamp":1784669159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N18X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSCH","BK4139","HELX","KRYS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653158270","title":"Construction Firm Tutor Perini Jumps on S&P Smallcap Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=2653158270","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653158270?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:57","pubTimestamp":1784638676,"startTime":"0","endTime":"0","summary":"BUZZ-Construction firm Tutor Perini jumps on S&P SmallCap inclusion** Infrastructure contractor Tutor Perini'sTPC.Nshares up 6.7% before the bell on Tues at $85.93 as co poised to join S&P SmallCap 600 index.SPCY** TPC to replace Krystal BiotechKRYS.Oin SPCY effective Fri, Jul 24, S&P Dow Jones Indices said late Mon** KRYS migrating to S&P MidCap 400 index.IDXto replace homebuilder Taylor MorrisonTMHC.N, which is beingacquiredby Berkshire HathawayBRKa.N** Shares of KRYS up 0.2% at $340.06 before the bell** Stephens analyst Melissa Roberts said in a note she expects passive funds will need to buy 6 mln TPC shares, which implies about 11 days of buying demand** Sylmar, California-based TPC has ~52.6 mln shares outstanding for $4.2 bln market cap** At Mon close, TPC stock up 20% YTD** All 5 brokerages covering the stock are bullish and their median PT is $118, per LSEG data","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL6N43N0NS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","LU2065169927.USD","TMHC","KRYS","LU2065171311.SGD","BK4088","TPC","LU2065170008.USD","LU2065171402.SGD","HELX","BK4139","BK4129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653275043","title":"Ligand Pharmaceuticals Inc : Citigroup Resumes Coverage with Buy Rating; Price Target $387","url":"https://stock-news.laohu8.com/highlight/detail?id=2653275043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653275043?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:12","pubTimestamp":1784628768,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","LGND","BK4007","BK4139","LU0566484027.USD","HELX","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653927662","title":"Ligand resumed with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2653927662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653927662?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:10","pubTimestamp":1784628616,"startTime":"0","endTime":"0","summary":"Citi resumed coverage of Ligand (LGND) with a Buy rating and $387 price target following the close of the Xoma acquisition. The firm views the deal...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ligand-resumed-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ligand-resumed-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HELX","BK4139","IE0009354923.USD","LU0566484027.USD","BK4007","LU1559883803.SGD","LGND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653241139","title":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Disposes of 5,000 Shares for $115,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2653241139","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653241139?lang=en_us&edition=fundamental","pubTime":"2026-07-21 07:20","pubTimestamp":1784589629,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 5,000 common shares on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL41gDrl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky Disposes of 5,000 Shares for $115,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADPT","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249554","title":"Tutor Perini Set to Join the S&P SmallCap 600 Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249554","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249554?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:44","pubTimestamp":1784583863,"startTime":"0","endTime":"0","summary":"Tutor Perini (TPC) will join the S&P SmallCap 600 index before market opens on July 24, the S&P Dow Jones Indices said in a late Monday statement.The company will replace Krystal Biotech (KRYS), which will join the S&P MidCap 400 index","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HELX","XSHQ","PSCH","LU2065171311.SGD","LU2065169927.USD","TPC","KRYS","BK4129","XJR","LU2065170008.USD","SBB","XSMO","SIXS","SDD","TPC.AU","LU2065171402.SGD","BK7136","QVMS","BK4139","SAA","RZV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249586","title":"Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249586","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249586?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:20","pubTimestamp":1784582423,"startTime":"0","endTime":"0","summary":"Berkshire Hathaway (BRK.B) (BRK.A) (BRK.A/BRK.B) is acquiring Taylor Morrison Home (TMHC) in a deal expected to close on or about that date, pendin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/krystal-biotech-to-replace-taylor-morrison-in-sp-400-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/krystal-biotech-to-replace-taylor-morrison-in-sp-400-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRYS","PSCH","HELX","TMHC","BK4088"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653249321","title":"Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24","url":"https://stock-news.laohu8.com/highlight/detail?id=2653249321","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653249321?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:20","pubTimestamp":1784582414,"startTime":"0","endTime":"0","summary":"17:18 EDT Tutor Perini (TPC) to replace Krystal Biotech (KRYS) in S&P 600 at open on 7/24 Published first on TheFly – the ultimate source for real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tutor-perini-to-replace-krystal-biotech-in-sp-600-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tutor-perini-to-replace-krystal-biotech-in-sp-600-at-open-on-7-24-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4129","PSCH","BK4139","LU2065169927.USD","LU2065171402.SGD","HELX","TPC","BK4581","BK4585","XBI","KRYS","LU2065171311.SGD","LU2065170008.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653467762","title":"S&P Dow Jones Indices Says Krystal Biotech Inc. Will Replace Taylor Morrison Home Corp. in the S&P Midcap 400","url":"https://stock-news.laohu8.com/highlight/detail?id=2653467762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653467762?lang=en_us&edition=fundamental","pubTime":"2026-07-21 05:17","pubTimestamp":1784582265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M11M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HELX","TMHC","BK4139","KRYS","PSCH","BK4088"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652099215","title":"Ligand price target raised to $345 from $330 at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2652099215","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652099215?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:46","pubTimestamp":1784551576,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Matt Hewitt raised the firm’s price target on Ligand (LGND) to $345 from $330 and keeps a Buy rating on the shares. Following ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ligand-price-target-raised-to-345-from-330-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ligand-price-target-raised-to-345-from-330-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HELX","LU0566484027.USD","IE0009354923.USD","BK4007","BK4139","LU1559883803.SGD","LGND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652236851","title":"Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2652236851","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652236851?lang=en_us&edition=fundamental","pubTime":"2026-07-18 09:05","pubTimestamp":1784336751,"startTime":"0","endTime":"0","summary":"Natera co-founder, Director Sheena Jonathan disposes of 1,500 common shares worth $410,322.91Natera director and co-founder Sheena Jonathan sold 1,500 common shares on July 15, 2026 at about $273 to $","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260718:nNDL9nvf8P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770308.USD","LU2065169927.USD","LU2065170008.USD","LU0053671581.USD","LU2065731478.USD","NTRA","LU2065171402.SGD","LU2264538146.SGD","GNOM","LU1988902786.USD","LU0345770993.USD","LU2065171311.SGD","BK4139","LU0963586101.USD","LU2324357040.USD","HELX","LU0012050646.USD","LU0106261612.USD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652330702","title":"Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 105,762 Common Shares Worth $2.39 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2652330702","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652330702?lang=en_us&edition=fundamental","pubTime":"2026-07-18 07:24","pubTimestamp":1784330673,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies Chief People Officer Francis Lo disposes of 105,762 common shares worth $2.39 millionAdaptive Biotechnologies Chief People Officer Francis Lo sold 105,762 shares on July 15 at","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL2NV8mT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of 105,762 Common Shares Worth $2.39 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ADPT","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652420159","title":"Natera Says Finalized Moldx Coverage Expands Prospera Surveillance Testing for Kidney, Heart, Lung Transplants","url":"https://stock-news.laohu8.com/highlight/detail?id=2652420159","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652420159?lang=en_us&edition=fundamental","pubTime":"2026-07-17 06:37","pubTimestamp":1784241425,"startTime":"0","endTime":"0","summary":"Natera says finalized MolDx coverage expands Prospera surveillance testing for kidney, heart, lung transplantsNatera flagged a final MolDx local coverage determination (L40060) expanding Medicare cove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL6Wxmx2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0963586101.USD","NTRA","LU2065731478.USD","LU2065169927.USD","BK4139","LU0012050646.USD","LU0053671581.USD","LU1064131342.USD","LU2264538146.SGD","LU2065171311.SGD","LU0345770308.USD","LU0345770993.USD","HELX","LU1988902786.USD","LU2324357040.USD","LU0106261612.USD","GNOM","LU2065170008.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652278224","title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2652278224","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652278224?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:57","pubTimestamp":1784235433,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa disposes of 116 common shares worth $18,941.64Guardant Health director Tariq Musa cut his stake to 11,182 shares following a sale disclosed in a Form 4.Musa sold 11","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDLc18J55:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","LU0109394709.USD","HELX","GH","BK4588","BK4535","GNOM","BK4551","LU0889565916.HKD","LU0320765992.SGD","LFSC","GDOC","EKG","BK4585","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651290441","title":"Guardant Health is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651290441","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651290441?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:10","pubTimestamp":1784203800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings(END) Dow Jones NewswiresJuly 16, 2026 08:10 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","BK4535","GDOC","LU0889565916.HKD","EKG","GH","PTH","LU0109394709.USD","GNOM","LU0320765992.SGD","BK4196","HELX","BK4588","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651446790","title":"Ligand Pharmaceuticals Inc : Benchmark Raises Target Price to $335 from $275","url":"https://stock-news.laohu8.com/highlight/detail?id=2651446790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651446790?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:20","pubTimestamp":1784200830,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43I17S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0566484027.USD","BK4139","HELX","LU1559883803.SGD","LGND","IE0009354923.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651344620","title":"Guardant Health price target raised to $190 from $160 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2651344620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651344620?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199651,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Guardant Health (GH) to $190 from $160 and keeps a Buy rating on the shares. The firm says its Q2 web ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-190-from-160-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","BK4535","GDOC","BK4588","GH","LFSC","LU0109394709.USD","EKG","BK4585","BK4551","GNOM","PTH","BK4196","LU0889565916.HKD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651925264","title":"Natera Co-founder, Director Sheena Jonathan Sells 3,150 Shares Worth $835,835.18","url":"https://stock-news.laohu8.com/highlight/detail?id=2651925264","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651925264?lang=en_us&edition=fundamental","pubTime":"2026-07-16 09:05","pubTimestamp":1784163957,"startTime":"0","endTime":"0","summary":"Natera co-founder, director Sheena Jonathan sells 3,150 shares worth $835,835.18Natera director and co-founder Sheena Jonathan sold 3,150 common shares on July 13, 2026 at about USD 262.72 to USD 268.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL7z6S8f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Co-founder, Director Sheena Jonathan Sells 3,150 Shares Worth $835,835.18","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU0012050646.USD","HELX","LU2065171311.SGD","NTRA","LU0963586101.USD","LU1988902786.USD","LU2065169927.USD","LU0106261612.USD","BK4139","LU0345770308.USD","LU2324357040.USD","LU1064131342.USD","LU2065731478.USD","GNOM","LU0345770993.USD","LU2065170008.USD","LU2065171402.SGD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}